|
Glenn L. Cooper, M.D. is chairman, and chief executive officer of Indevus. Dr. Cooper was previously president and chief executive office of Progenitor, Inc. and executive vice president and chief operating officer of Sphinx Pharmaceuticals Corporation. He also has held several positions with Eli Lilly and Company, including: director, clinical research, Europe, of Lilly Research Center Limited, and international medical advisor and medical advisor, regulatory affairs, at Lilly Research Laboratories. He received his M.D. from Tufts University School of Medicine, performed his postdoctoral training in internal medicine and infectious diseases at the New England Deaconess Hospital and Massachusetts General Hospital, and received his A.B. from Harvard College. | 